Why take this course?
Packaging and labeling occupy a critical position within the pharmaceutical supply chain, connecting product development with manufacturing, distribution, and product launch activities. As AI and machine learning accelerate production capabilities, packaging and labeling operations must evolve to support higher output without increasing the likelihood of errors. Effective controls become increasingly important to maintain accuracy, support timely delivery, and ensure that packaging activities keep pace with changing manufacturing demands.
This webinar examines how packaging and labeling controls can reduce hidden errors before they affect product launches, supply chain performance, or operational efficiency. Participants will evaluate the changing landscape created by AI-assisted manufacturing, the role of packaging and labeling in process improvement, and the importance of proactive decision-making, process mapping, and resource allocation. The session also addresses practical approaches for reducing errors while strengthening production capability and supporting evolving supply chain expectations.
Key Areas Covered
Michael Esposito
Michael Esposito has 30 years of pharmaceutical industry experience and 13 years in GMP training and document management. His background includes packaging, Quality Assurance, project administration, systems training, and international operations at major pharmaceutical companies, providing practical experience directly relevant to packaging controls, process improvement, and product launch activities.
Commonly Asked Questions About This Subject
How can packaging and labeling controls appear compliant while hidden errors continue reaching production?
Inspection observations often reveal that individual control steps function exactly as intended, yet the overall process still permits errors to pass undetected. Each review, approval, and verification activity may be completed correctly, but no one evaluates how information changes as it moves across departments.
Hidden errors commonly develop during transfers between regulatory affairs, artwork development, packaging engineering, manufacturing, supply chain, and printing vendors. Product codes, market-specific requirements, revision histories, serialization data, or approved text can gradually diverge even though every group believes it is working from approved information.
Inspection friction develops when organizations demonstrate procedural compliance but cannot explain how consistency is maintained across the complete packaging lifecycle.
Evidence that carries weight includes end-to-end traceability of approved content, documented reconciliation between connected systems, cross-functional review records, and verification that every downstream activity reflects the same approved product information rather than independently maintained copies.
When should a labeling revision trigger a broader process review rather than a routine document update?
A practical decision point arises when a seemingly small labeling change influences activities well beyond artwork approval. Updates affecting indications, warnings, dosage instructions, storage conditions, product identification, or market-specific requirements frequently extend into manufacturing, distribution, inventory management, training, validation, and customer communication.
Rework often begins because the revision was treated as an isolated documentation task instead of an operational change. Production materials, warehouse inventory, electronic systems, packaging specifications, and associated procedures may remain aligned with the previous version despite formal approval of the new labeling.
Reviewers generally look for evidence that the organization evaluated downstream impacts before implementation rather than discovering them afterward through deviations or complaints.
Well-controlled change processes examine the operational consequences of the revision across the complete product lifecycle instead of limiting the assessment to the label itself.
What becomes most difficult to defend after a packaging or labeling mix-up has occurred?
Documentation concern: the hardest position to defend is that multiple independent controls failed without understanding why they failed together. Inspectors usually examine the complete sequence of events rather than focusing on the final error.
Packaging investigations often reveal that barcode verification, line clearance, reconciliation, visual inspection, electronic approvals, or operator checks all functioned individually but shared the same underlying weakness. Personnel may have relied on identical assumptions, the same incorrect source data, or a common workflow that allowed the error to progress.
Corrective actions become less convincing when they strengthen only the final checkpoint while leaving earlier decision points unchanged.
Evidence supporting a thorough investigation includes reconstruction of the complete process, evaluation of every failed opportunity to detect the issue, and identification of the systemic conditions that allowed multiple controls to become ineffective simultaneously.
How should organizations evaluate AI-assisted packaging and labeling tools without weakening human oversight?
A governance concern emerges when personnel gradually accept AI-generated recommendations as completed work rather than as information requiring professional evaluation. Packaging and labeling activities often involve numerous repetitive decisions, making automation particularly attractive.
Inspection questions are likely to focus on situations where AI proposes artwork changes, detects inconsistencies, prioritizes reviews, or supports proofreading. Reviewers generally expect personnel to explain how incorrect recommendations would be recognized before implementation.
Documentation becomes weaker when review records simply confirm that AI output was accepted without describing the human evaluation that followed.
Evidence of effective oversight includes documented review criteria, examples where recommendations were modified or rejected, defined escalation pathways for uncertain outputs, and periodic assessment of AI performance. Those records demonstrate that technology supports packaging decisions while accountability for product labeling remains firmly under human control.
Your TalkFDA Webinar Experience
1. Confirmation
3. Join the Live Training
4. Watch Again Anytime
Testimonials
Ready to Strengthen Your Team? Let’s Build Your Training Plan.
Your team deserves the clarity.
Your organization deserves the confidence.


